Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction—Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial-Reference-Cited by-同舟云学术

Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction—Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial

Published:2020-06 Issue: Volume:224 Page:129-137
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Duengen Hans-Dirk,Kim Raymond J.,Zahger Doron,Orvin Katia,Kornowski Ran,Admon Dan,Kettner Jiri,Shimony Avraham,Otto Christiane,Becka Michael,Kanefendt Friederike,Romo Andres Iniguez,Hasin Tal,Ostadal Petr,Rojas Gonzalo Calvo,Senni Michele,Podpera Ivo,Linkova Hana,Hajek Petr,Bauersachs Johann,Menck Niels,Fuisting Jan,Oumbe Tiam Sadrack,Martinez Selles Manuel,Miro Palau Vicente,Roque Mercedes,Ibanez Borja,Arbel Yaron,Nikolsky Eugenia,Nodari Savina,Silvio Marenzi Gian Carlo,Achilli Felice,Reimers Bernhard

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the fast-mi program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015;Puymirat;Circulation,2017

2. Postinfarct left ventricular remodelling: a prevailing cause of heart failure;Galli;Cardiol Res Prac,2016

3. Patterns of post-MI left ventricular volume changes – clinical implications;Brzezinska;Kardiol Pol,2007

4. Time course of infarct healing and left ventricular remodelling in patients with reperfused ST segment elevation myocardial infarction using comprehensive magnetic resonance imaging;Ganame;Eur Radiol,2011

5. Late cardiac remodeling after primary percutaneous coronary intervention-five-year cardiac magnetic resonance imaging follow-up;Springeling;Circ J,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine;Cardiovascular Pathology;2024-07

2. Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity;Animals;2024-04-02

3. Update on Mast Cell Proteases as Drug Targets;Immunology and Allergy Clinics of North America;2023-11

4. Is chymase 1 a therapeutic target in cardiovascular disease?;Expert Opinion on Therapeutic Targets;2023-08-03

5. The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention;European Journal of Internal Medicine;2023-06